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ABSTRACT
Modification of cellular proteins with molecules of ubiquitin is an important
process that regulates the activity of cellular proteins. Cullin RING ligases (CRLs) are
multi-subunit complexes that act in concert with E2 enzymes to attach molecules of
ubiquitin to protein substrates. There are seven CRLs in mammalian cells (Cul1, Cul2,
Cul3, Cul4A, Cul4B, Cul5, and Cul7) that are highly homologous in sequence and
structure. CRLs possess a highly conserved C- terminal domain that interacts with E2
enzymes, and a more variable N- terminal domain which recruits substrates through
distinct substrate adapter molecules. Despite the structural similarity, these CRLs
recognize distinct substrates and carry out unique functions in cells.
In order to characterize the functional domains of cullins that are responsible for
their unique activity, we generated cullin chimeras for expression and analysis in
mammalian cells. These chimeras are Cul3 mutants in which the C- terminal domain or
N- terminal domain of Cul3 has been replaced by that of Cul1 or Cul2, respectively.
These chimeras were cloned into a mammalian expression vector for the purpose of
experimentation in cultured cells.
The chimeric cullin constructs provided a valuable tool for investigating how
different functional domains of CRLs contribute to their specific functions in cells. In this
study, we first investigated if the chimeras that we engineered were able to interact with
their respective substrate adapters. We performed co- immunoprecipitation experiments
in which we tested the ability of wild type, chimeric, or mutant cullin proteins to bind to
three different substrate adapter proteins. We found that the chimera possessing the Ci

terminus of Cul1 and the N- terminus of Cul3 retains the ability to interact with the BTB
substrate adapters Ctb57 and KLHL3. We also found that the chimera that possesses the
C- terminus of Cul3 and the N- terminus of Cul1 was unable to interact with BTB
proteins. Lastly, we found that the Cul1 adapter Skp1 was able to bind to Cul1, but did
not bind to Cul3 or either chimera. We concluded that the chimera possessing the Nterminus of Cul3 likely retains the functional binding abilities of Cul3 at the N- terminus
and would therefore be useful for conducting experiments.
In this study, we also used the cullin chimeras to investigate the binding
interactions between E2 enzymes and cullin RING ligases. We performed coimmunoprecipitation assays to examine the interactions between E2 enzymes and wild
type, mutant or chimeric cullin proteins. We found that E2 enzyme UbE2E1 selectively
binds to Cul3 and not to Cull. Notably, the BTB binding region at the N- terminus of
Cul3 is required for binding to UbE2E1. Furthermore, we found that UbE2E1 also binds
to Cul3 substrate adapter protein Ctb57. These experiments revealed a novel interaction
between and E2 enzyme and the N- terminus of Cul3, as well as with a Cul3 substrate
adapter protein. In conclusion, the chimeras generated in this study have provided
valuable information regarding what regions of CRLs are important for interactions with
other proteins, and will continue to be a useful tool for investigating CRL structure and
function.
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CHAPTER I
INTRODUCTION
Post- translational modification of cellular proteins is required for nearly all
biological processes in living cells. The covalent attachment of functional groups or small
polypeptides to cellular proteins results in an alteration of protein activity, thereby
orchestrating numerous biological pathways. There are many examples of posttranslational modifications, including phosphorylation, acetylation, glycosylation, and
ubiquitination. These modifications participate in complex signaling networks in living
cells. Therefore, understanding how these modifications occur is fundamental to
understanding cell biology.
Modification with ubiquitin governs the activity of proteins in cells, much like to
phosphorylation. Ubiquitin is a small, highly conserved polypeptide composed of 76
amino acids. Attachment of ubiquitin targets proteins for a variety of fates in cells,
notably degradation by the 26S proteasome (Ciechanover et al., 1981). During ubiquitin
conjugation events, molecules of ubiquitin are attached to targeted substrates by the
concerted action of enzymes designated E1, E2, and E3. The ubiquitin activating enzyme,
E1, forms an ATP dependent thio-ester bond with a molecule of ubiquitin, which is then
transferred to the active site cysteine of an E2 ubiquitin- conjugating enzyme. An E2 then
acts in concert with an E3 ubiquitin ligase to covalently attach ubiquitin to lysine residues
of substrates (Hershko et al., 1981). This pathway is illustrated in Figure 1.
Attachment of multiple molecules of ubiquitin through repetition of the catalytic
cycle results in the assembly of a polyubiquitin chain, which targets the substrate for
1

degradation by the 26S proteasome (Ciechanover et al., 1981). Alternatively, attachment
of a single molecule of ubiquitin also destines proteins for non-degradative outcomes.
Examples include membrane protein endocytosis and trafficking, protein kinase
activation, and chromatin remodeling (Chen et al., 1996; Chen and Sun, 2009; Hicke,
2001). Thus, ubiquitin modification allows cells to tightly control the timing, abundance,
activity, and localization of proteins involved in numerous important pathways.
E3 UBIQUITIN LIGASES
E3 ubiquitin ligases are responsible for the recognition and recruitment of
substrates for ubiquitin modification. Since E3 ligases confer substrate specificity, they
play a central role in regulating proteins and thus are an important coordinator of many
biological processes. E3 ligases fall into two broad categories: HECT- type E3’s
(homologous to E6-AP C-terminus) which possess catalytic activity and directly bind
molecules of ubiquitin prior to conjugation to substrate, and RING- type E3’s (ReallyInteresting- New- Gene) which contain a RING-finger domain and serve as molecular
scaffolds, positioning protein substrate in proximity to E2 enzymes for ubiquitin transfer.
Our laboratory studies members of a family of RING-type E3s known as the Cullin
RING ligases (CRLs). Three important CRLs used in this study are introduced here.
CULLIN RING LIGASES (CRLS)
CRLs are multi-subunit complexes that assemble in a modular fashion around a
central cullin core. There are at least seven cullins in humans (Cul1, Cul2, Cul3, Cul4A,
Cul4B, Cul5, and Cul7) that are thought to be highly similar in architecture (Feldman et
al., 1997; Kipreos et al., 1996; Mathias et al., 1996). Cullin complexes act as a molecular
2

scaffold, recruiting and positioning substrates into close proximity of E2 enzymes for
ubiquitin conjugation. The most well-characterized cullin complex is the SCF complex
(Skp-1/ Cul1/ F-box), which has been extensively studied for its role in regulation of cell
cycle proteins. The SCF complex has been shown to regulate cyclins D and E, as well as
the cyclin dependent kinase inhibitors p27 and p21 (Ganoth et al., 2001; Kipreos et al.,
1996; Yu et al., 1998). Thus, the SCF complex is an important regulator of the G1-S
transition and cell cycle progression.
Crystallographic analysis into the structure of the SCF complex revealed that the
complex consists of multiple subunits assembled around a central cullin protein (Cul1).
The globular C- terminal region of Cul1 binds the RING domain protein Rbx1, which
serves as a docking site for ubiquitin- activated E2. The N- terminal region of Cul1
binds the adaptor protein Skp1, which interacts with F-box proteins bearing protein
interaction domains responsible for the recognition of substrate (Zheng et al., 2002). The
SCF complex was among the earliest CRL complexes to be characterized, and has since
served as a model for the structure of cullin complexes.
Another well- characterized cullin complex is the ECS complex (ElonginC/Cul2/SOCS box), which has been well characterized for its role in the human genetic
disorder von Hippel-Lindau syndrome. ECS targets a host of unique protein substrates for
degradation, including the transcription factor hypoxia inducible factor 1 α (HIF α). VonHippel-Lindau syndrome results from mutations in the gene which codes for the Cul2
substrate adapter protein VHL. Mutations in VHL interrupts the ability of the complex to
target HIF α for degradation, leading to a buildup of this transcription factor and
3

predisposing individuals to the formation of tumors (Maher and Kaelin, 1997). Like the
SCF complex, VHL/Cul2 also assembles into a multi-subunit complex, binding Rbx1 and
an ubiquitin activated E2 at its C- terminus, while interacting with substrates at its Nterminus via the adapter proteins Elongin B /C and the substrate adapter VHL (Pause et
al., 1997).
A more- recently discovered cullin family member, Cul3, appears to share a
similar structure and is currently being characterized by our laboratory and others. Since
its discovery, Cul3 has been shown to recognize and recruit a growing number of diverse
substrates in mammalian cells. Our laboratory has demonstrated that Cul3 is required for
normal development in mouse embryos, as the loss of Cul3 leads to early embryonic
arrest (Singer et al., 1999). Cul3 plays a role in many fundamental processes, as it has
been shown to regulate such diverse substrates as the microtubule severing protein p60/
katanin, transcription factor Nrf2, and meiotic spindle- formation factor Mei1 (Cummings
et al., 2009; Pintard et al., 2003; Zhang et al., 2004). We have also shown that Cul3 is
required for the degradation of cyclin E, and thus is another important player in cell cycle
regulation (Singer et al., 1999), (McEvoy et al., 2007).
A growing body of evidence suggests that all CRLs share a similar modular
architecture consisting of three distinct functional domains: an N-terminal domain which
binds adaptor proteins responsible for substrate recognition and recruitment, a stalk- like
central domain, and a highly conserved globular C-terminal domain known as the cullin
domain (Pause et al., 1999; Pintard et al., 2004; Willems et al., 2004). A conserved site in
the cullin domain binds the RING domain protein Rbx1 (also referred to as Hrt1, Rub1,
4

or Roc1), which serves as a docking site for ubiquitin activated E2 enzymes (Kamura et
al., 1999; Ohta et al., 1999; Seol et al., 1999; Tan et al., 1999).
The C- termini of CRLs are also modified with a molecule of NEDD-8 (Neural
precursor cell Expressed Developmentally Down-regulated protein 8).

NEDD-8 is a

small, ubiquitin like molecule that is covalently attached to a conserved lysine residue in
the cullin domain of CRLs. Neddylation is thought to be required for CRL activation and
ubiquitylation activity, presumably by inducing a conformational change in the RING
domain which positions the E2 in closer proximity to substrate for ubiquitin transfer
(Hori et al., 1999; Ohh et al., 2002; Pan et al., 2004).
While the C- terminal domain of cullins is highly conserved, the N- terminus is
more variable and interacts with protein substrates via different, but related modules.
Cul1 interacts with substrates through adaptor Skp1, which binds separate protein
recognition subunits called F-box proteins. Cul2 binds the adapter Elongin C, which
interacts with substrate via separate SOCS box proteins (Stebbins et al., 1999). Cul3
recognizes substrates through a single adaptor protein that binds to Cul3 via a BTB
domain (Bric a Brac, Tramtrack, and Broad- complex) and recognizes substrates through
various protein-protein interaction motifs such as Kelch, Zinc Finger, or MATH domains
(Stogios et al., 2005).

The modular assembly of these three cullin complexes is

illustrated in Figure 1.2.
While Cul1, Cul2, and Cul3 complexes are highly similar in structure, they target
distinct substrates and thus perform unique functions in cells. The work described in this
thesis aimed to characterize the regions of Cul3 that are responsible for its specific
5

functions in mammalian cells. Toward this goal, we created Cul3 mutants in which the Cterminal region and N- terminal region of Cul3 has been replaced by that of Cul1 or Cul2,
respectively. This was achieved by using molecular cloning techniques to swap out the
coding regions of Cul3 DNA which correspond to the C- terminal and N- terminal region
of the Cul3 protein with that of Cul1 or Cul2. These cullin chimeras were cloned into a
mammalian expression vector, which allowed us to express these chimeric proteins in
cultured cells, and perform experiments to characterize the binding interactions and
activity of the chimeras in cells. The information gained from these experiments has
provided valuable insight into which regions of the Cul3 protein are essential for its
unique interactions and functions.
The cullin chimeras have provided a direct approach to addressing specific
questions regarding CRL complex assembly. For example, the model suggests that the
homologous C- termini of Cul1, Cul2, and Cul3 bind the RING protein Rbx1, which
serves as a docking site for ubiquitin- activated E2 enzymes. E2 enzymes then work in
concert with CRLs to attach molecules of ubiquitin to substrates.
While 38 E2 enzymes have been identified in humans, little is known about how
specific E2s are recruited to CRLs. Given that the cullin domain is highly conserved, and
all cullins bind Rbx in a similar way, then how do certain E2s bind one CRL and not
another? What structural features of different cullins are required for interactions with
different E2 enzymes?
It has been suggested that E2 enzymes are responsible for selecting which lysine
residues of substrates are ubiquitinated, as well as for the type of ubiquitin chains that are
6

attached to substrates (Jin et al., 2008; Kim et al., 2007). Since both the placement and
branching of ubiquitin chains play a major role in the fates of substrates, the interactions
between CRL complexes and E2s are very important for understanding cullin specific
functions in vivo.
The chimeric approach has allowed us to test the current model of CRL complex
assembly, and directly address the important questions posed above. For example, in
order to characterize what part of CRL complexes are required for binding to E2
enzymes, we cotransfected wild type and chimeric cullins with several different E2
enzymes in cultured cells. Immunoprecipitation experiments revealed novel interactions
between cullins and E2s, and also contributed important information regarding which
regions of cullins are participating in these E2 interactions.
Beyond characterizing binding interactions, the chimeric cullins will also be used
to investigate Cul3 specific functions in vivo. The ultimate goal for the chimeras
generated in this study is to perform complementation assays to determine if the chimeras
are capable of performing Cul3 specific functions in cultured cells. At the time of this
writing, these experiments have not yet been carried out, but represent an important
future goal for this work.
For the complementation assays, we possess a conditional knock out of the Cul3
gene in mouse embryonic fibroblasts (MEFs), wherein the addition of drug to these cell
lines results in the deletion of Cul3. Since we have shown that the deletion of Cul3 in
mice results in early embryonic arrest, deletion of Cul3 in cultured cells is expected to
have certain observable phenotypes. Therefore, complementation experiments can be
7

performed in which each chimera is introduced separately into MEFs, after which
endogenous Cul3 will be deleted. These cell lines will then be analyzed to determine if
chimera expression was able to rescue the phenotypes associated with the loss of Cul3.
Thus, these experiments will allow us to begin to characterize what regions of Cul3 are
required for Cul3 specific functions.
The work described in this thesis addresses important questions regarding CRL
complex assembly and function in mammalian cells, and is organized into five chapters.
The design and construction of the cullin chimeras are discussed in detail in Chapter II.
The binding of wild type and chimeric cullin proteins to substrate adapters in cullin
complexes is examined in Chapter III. Wild type and chimeric cullin binding to E2
enzymes is discussed in Chapter IV.

Finally, the significance and future directions for

this study are discussed in Chapter V.
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Figure 1.1: The Ubiquitin Pathway
Ubiquitin is attached to protein substrates by the concerted action of enzymes E1, E2, and E3. The
ubiquitin activating enzyme E1 forms a high energy bond with a molecule of ubiquitin, and transfers the
ubiquitin to the active site of an ubiquitin conjugating enzyme E2. The E2 enzyme then works in concert
with an E3 ubiquitin ligase to attach molecules of ubiquitin to lysine residues of protein substrates.
Repetition of this catalytic cycle can result in the assembly of a polyubiquitin chain, which targets the
substrate for degradation by the 26S proteasome.

9

Figure 1.2: The modular structure of Cullin Ring Ligases
Cullin ring ligases Cul1, Cul2, and Cul3 assemble into multisubunit complexes that are structurally similar.
The C- termini of these cullins are highly homologous, and bind the RING domain protein Rbx1, which
serves as a docking site for ubiquitin conjugated E2 enzymes. A conserved lysine residue at the C- termini
of cullin complexes is modified with a molecule of Nedd- 8, which is thought to activate cullin complexes
by inducing a conformational change in the cullin protein which positions the E2 in closer proximity to
substrate for ubiquitin transfer. The N- terminal regions of these cullins are more variable and interact with
protein substrates via distinct protein modules. Cul1 interacts with substrate through the adapter protein
Skp1 and substrate binding subunits known as F- box proteins. Cul2 recruits substrates through the adapter
Elongin C and substrate binding SOCS- box proteins. While Cul1 and Cul2 bind substrates via two separate
subunits, Cul3 interacts with substrates via a single polypeptide, which binds to Cul3 though a BTB domain
and interacts with substrates via variable protein interaction motifs.
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CHAPTER II
GENERATION AND EXPRESSION OF CHIMERIC CUL3 PROTEINS
ABSTRACT
Cul1, Cul2, and Cul3 are three closely related cullin RING ligases (CRLs) that act
in concert with E2 enzymes to attach molecules of ubiquitin to protein substrates. These
CRLs possess a highly conserved C- terminal domain that interacts with E2 enzymes, and
a more variable N- terminal domain which recruits substrates through distinct substrate
adapter molecules. Despite the structural similarity, these CRLs recognize distinct
substrates and carry out unique functions in cells. In order to characterize the functional
domains of Cul3, we generated cullin chimeras for expression and analysis in mammalian
cells. These chimeras are Cul3 mutants in which the C- terminal domain or N- terminal
domain of Cul3 has been replaced by that of Cul1 or Cul2, respectively. These chimeras
were cloned into a mammalian expression vector for the purpose of experimentation in
cultured cells. All of the plasmids were sequenced and it was confirmed that the inserts
were correct and in frame. The plasmids were transfected into cultured cells, and western
blotting was used to visualize the expression of chimeric cullin protein. The chimeras all
appeared to be modified with Nedd-8, which suggested that the chimeras are likely folded
into the proper confirmation. Here the design and construction of the chimeras are
discussed in detail.
INTRODUCTION
Chimeric analysis is extremely valuable for investigating the structure and
function of homologous members of protein families. Since members of protein families
11

are often descendants from a single gene that has undergone duplications, homologues
within the same family frequently have similar structure yet divergent functions. Thus,
the generation of a chimeric protein where similar structural domains can be swapped is a
valuable tool for investigating the divergent roles of closely related proteins.
Classical examples of chimeric analysis can be seen in studies involving nuclear
hormone receptors. The nuclear hormone receptors are members of a protein superfamily
which regulate transcription in response to binding of hormone ligands. These proteins
are essentially made up of two main domains: a ligand binding domain and a DNA
binding domain. Each receptor binds to specific DNA sequences and activates
transcription of certain genes in response to binding of hormone molecules. Swapping
out different DNA binding or ligand binding domains among different nuclear hormone
receptors using chimeric cloning techniques provided many researchers with a systematic
way to examine the roles of these functional domains in different receptors in cells.
The experiments described in this thesis used chimeric analysis to characterize the
functional domains of Cul3, an important member of the cullin family of E3 ligases. As
described in Chapter I, the current model for cullin complex assembly suggests that
cullins consist of three main domains: an N- terminal domain that recruits substrate, a
stalk like central domain, and a globular C- terminal domain. The chimeric cullins
constructs generated in this study code for Cul3 fusion proteins in which the N- terminal
(substrate recognition) region or C- terminal (E2 binding) regions have been replaced by
that of Cul1 or Cul2, respectively. These cullin chimeras were created in a mammalian
expression vector, allowing us to express these chimeric proteins in cultured cells, and
12

perform experiments to characterize the structural features of different cullins that make
their activity unique.
In this chapter, the design and construction of the chimeric cullin constructs is
described in detail. Four chimeras were generated: Two chimeras that are essentially
Cul3 with the N- terminus of Cul1 or Cul2 respectively (named Cul1 NTD and Cul2
NTD); and two chimeras that are Cul3 with the C- terminus of Cul1 or Cul2 respectively
(named Cul1 CTD and Cul2 CTD). A schematic illustrating these chimeric cullins can be
seen in Figure 2.1.
DESIGN AND CONSTRUCTION OF CULLIN CHIMERAS
The first step in the design of the chimeras was to clearly define the N- terminal
and C- terminal domains in the amino acid sequences of Cul1, Cul2, and Cul3. For the Nterminus, this was achieved by searching through published data for what is known about
which amino acids appear to be required for each cullin to bind their respective substrate
adapters. While the N- termini of different cullins are variable, they all possess a similar
motif consisting of three repeats each made up of a five helix bundle, which is termed the
cullin repeat. Studies performed on the SCF complex determined that the interaction
between Cul1 and Skp1 resides in helix one within most N terminal repeat, which
consists of approximately 120 amino acids (Zheng et al., 2002) . For the Cul2 complex, a
study using deletion mutants suggested that Cul2 binding to Elongin C requires the first
158 amino acids (Pause et al., 1999). Finally, several studies using deletion mutants have
suggested that the amino acids required for Cul3 binding to BTB proteins reside on helix
2 and helix 5 of the most N- terminal cullin repeat (Pintard et al., 2004; Pintard et al.,
13

2003; Xu et al., 2003). Therefore, in the design of the chimeric constructs, we made
certain that the N- terminal domains to be swapped each encompassed the residues
required for interaction with their respective substrate adapters.
The C- terminal domains of Cul1, Cul2, and Cul3 were defined by entering the
amino acid sequences for each cullin into the NCBI conserved domain search tool. As
described in Chapter I, the C- terminus of cullins possesses a highly conserved globular
domain referred to as the cullin domain. Encompassing a stretch of approximately 150
amino acids, the cullin domain is required for interaction with RING domain proteins
such as Rbx1 (Ohta et al., 1999).
Therefore, in the design of the C- terminal chimeras, we made certain that the
defined C- terminal regions for each cullin encompassed the stretch of amino acids
identified as the cullin domain by the NCBI conserved domain search tool. It should also
be noted that the neddylation site for all three of these cullins lies downstream of the
cullin domain. Thus, the defined C- terminal domain for each cullin also encompassed
the site of Nedd-8 modification.
Once the N- terminal and C- terminal regions of Cul1, Cul2, and Cul3 were
clearly defined, we then used protein alignment software to determine where to place the
chimeric junctions within the protein sequences of each cullin. We wanted to create the
junctions within a stretch of amino acid sequence that is relatively conserved between the
three cullins, so that the changes made to the amino acid sequence in that area would be
minimal and unlikely to disturb the way in which the chimeric protein folds. Therefore,
we performed an alignment on Cul1, Cul2, and Cul3 amino acid sequences using
14

CLUSTALW software. The placement of the chimeric junctions was chosen in areas of
relatively high homology between the three cullins, and also such that each junction
separated the predefined N- terminal and C- terminal regions for each cullin. The amino
acid alignment and the placement of the chimeric junctions are shown in Figure 2.2.
Once the N- terminal and C- terminal regions were defined and the placement of
the junctions in the cDNA determined, the next step was to use molecular cloning
techniques to generate the chimeric constructs. The cloning strategy is illustrated in
Figure 2.3 and is also described here:
First, wild type Cul3 cDNA was cloned into the mammalian expression vector
used in this study. The cloning was carried out by use of PCR that generated the coding
region of the human Cul3 gene flanked by two unique restriction sites at the 5’ and 3’
ends, respectively. These restriction sites were chosen so that restriction digests could
later be used to swap out the 5’ and 3’ regions of Cul3 cDNA that correspond to the Nterminal and C- terminal regions of the Cul3 protein, respectively.
The chimeric constructs containing the N- terminal regions of either Cul1 or Cul2
were created by utilizing a third unique restriction site located approximately 300 base
pairs into the coding region of Cul3. A restriction site at this location was chosen because
it would allow us to use restriction digests to cut out and replace the coding region that
corresponds the N- terminus of Cul3. To create the N- terminal Cul3 chimeras, DNA
fragments corresponding to the N- terminal regions of Cul1 or Cul2 were generated by
PCR, flanked by the same two restriction sites that flank the N-terminal region in the wild
type Cul3 plasmid. Restriction digests and ligations were then carried out resulting in
15

constructs coding for two chimeric cullins: Cul3 mutants with the N-terminal region
replaced by that of Cul1 or Cul2, respectively.
The Cul3 chimeras that contain the C-terminal regions of either Cul1 or Cul2
were created similarly, with one notable difference. In the wild type Cul3 plasmid, there
was not a unique restriction site upstream of the C-terminal region that we wished to
replace. Therefore, we created an additional unique restriction site using site directed
mutagenesis. PCR reactions were then performed to generate C-terminal fragments of
Cul1 and Cul2 also flanked by the same two restriction sites that flank the C- terminal
region in the wild type Cul3 plasmid. Subsequent restriction digests and ligation reactions
resulted in constructs coding for two additional chimeras: Cul3 mutants with the Cterminal region replaced by that of Cul1 or Cul2 respectively.
The chimeric constructs were sequenced, to verify that the N- terminus and C
terminus of Cul3 had indeed been replaced by that of Cul1 or Cul2. The sequencing data
confirmed that the chimeric junctions were created as intended. The constructs were then
separately transfected into cultured HEK 293 cells, to verify that the plasmids were able
to express chimeric cullin proteins in cells. Importantly, the plasmids were all capable of
expressing chimeric protein in cultured cells, providing us with a valuable experimental
tool for investigating CRL structure and function. Lastly, all four chimeras appear to be
modified with Nedd-8, indicating that they are likely properly folded.

16

MATERIALS AND METHODS
Molecular cloning techniques
Standard molecular techniques were used to clone wild type and chimeric cullins
into the mammalian expression vector pCMV-3Tag-6. The templates and primers used
for PCR are provided here, as well the enzymes used for restriction digests.
PCR was used to generate wild type human Cul1, Cul2, and Cul3 coding regions
using pcDNA templates. The primers used were designed to produce PCR product
flanked by restriction sites for cloning into the pCMV-3Tag6 vector. Thus, the restriction
sites flanking the wild type cullin coding regions in pCMV-3Tag-6 are as follows: Cul1 is
flanked by Srf1 and BamHI, and Cul2 and Cul3 are both flanked by SrfI and ClaI.
The following primer sequences were used for wild- type cullin PCR :
Cul1 forward primer: 5’CAC TTG GCC CGG GCA ATG TCG TCA ACC CGG AGC 3’
Cul1 reverse primer: 5’ CAC GTT GGA TCC TTA AGC CAA GTA ACT GTA GGT
GTC C- 3’
Cul2 forward primer: 5’ CAC TTG GCC CGG GCA ATG TCT TTG AAA CCA AGA3’
Cul2 reverse primer: 5’- CAC GTT ATC GAT TCA CGC GAC GTA GCT GTA- 3’
Cul3 forward primer: 5’ CAC TTG GCC CGG GCA ATG TCG AAT CTG AGC AAA3’
Cul3 reverse primer: 5’ CAC GTT ATC GAT TTA AGC CAA GTA ACT GTA GGT
GTC C-3’
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FLAG- tagged chimeric cullins were created as described in the introduction section.
PCR was used to generate NTD and CTD coding regions for both Cul1 and Cul2
respectively. These PCR reactions used pcDNACul1 and pcDNACul2 as templates. The
primers used were designed to produce PCR product flanked by restriction sites for
cloning into pCMV-3Tag-6 Cul3, replacing the NTD and CTD of Cul3 in this vector.
Both NTD PCR products were flanked by the restriction sites Srf1 and HindIII, while
both CTD PCR products were flanked by the restriction sites MfeI and ClaI.
The following primer sequences were used for the NTD and CTD PCR:
Cul1 NTD forward primer: 5’CAC TTG GCC CGG GCA ATG TCG TCA ACC CGG
AGC 3’
Cul1 NTD reverse primer: 5’- GCG CAA GCT TGT TGA GTG TAG AAT TTC AGT
ACA CT- 3’
Cul2 NTD forward primer: 5’ CAC TTG GCC CGG GCA ATG TCT TTG AAA CCA
AGA3’
Cul2 NTD reverse primer: 5’- GGC CAA GCT TGC CTA TGA TAC ATA ACA AGT
ACT TGT TCT TC- 3’
Cul1 CTD forward primer: 5’- GGC CCA ATT GGA ACT AGA AGA CAC ACT CAA
TCA ACT GAT- 3’
Cul1 CTD reverse primer: 5’ CAC GTT ATC GAT TTA AGC CAA GTA ACT GTA
GGT GTC C- 3’
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Cul2 CTD forward primer: 5’- GGC CCA ATT GGA AGT GGA AGA CAG GCT CAC
GAG CTT CAT 3’
Cul2 CTD reverse primer: 5’ CAC GTT ATC GAT TCA CGC GAC GTA GCT GTA 3’
Site directed mutagenesis
The restriction sites used for cloning the N- terminal Cul1 and Cul2 fragments
into the Cul3 vector were already present, flanking the N- terminal region Cul3. For the
C- terminus however, we created the MfeI restriction site using site directed mutagenesis.
The MfeI site was created by the addition of a single codon (TTG) at the position where
we wished to create the C- terminal chimeric junction (between nucleotides 1218-1219).
This insertion should result in the addition of a single leucine residue in the amino acid
sequence of Cul3, between residues 406 and 407. Site directed mutagenesis was done
using the QuikChange site directed mutagenesis kit (Agilent technologies).
Cell culture, transfections and western blotting
HEK (Human Embryonic Kidney) 293 cells were grown in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 1% L- glutamine,
and 1% penicillin/streptomycin.
Transfections were carried out using calcium phosphate precipitation as described
previously (Clurman et al., 1996).
Western blotting was performed as follows: Approximately 48 hours after
transfection, cells were harvested in versene (1mM EDTA in phosphate-buffered saline).
Cells were lysed in radioprecipitation assay (RIPA) buffer supplemented with protease
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inhibitor, and phosphatase inhibitor, and 1mM DTT. Lysates were sonicated for 10
seconds. SDS PAGE was used to separate protein in the samples on 10% acrylamide gels,
followed by a transfer to nitrocellulose membrane. The membranes were incubated
overnight in primary antibodies. Proteins on the membrane were visualized using
horseradish

peroxidase

conjugated

secondary

antibodies

and

enhanced

chemiluminescence reagent, followed by detection of signal on a digital imager.
Antibody used: anti- FLAG M2 monoclonal antibody (Sigma Aldrich).
Molecular modeling
A molecular model of a chimeric cullin was generated using Visual Molecular Dynamics
(VMD) software, downloaded from the NIH Center of Macromolecular Modeling and
Bioinformatics: http://www.ks.uiuc.edu/Research/vmd
The protein data bank coordinates for the Cul1/Rbx1 crystal structure were obtained from
the RSCB Protein Data Bank (PDB ID: 1 ldj).
The molecular model was generated by uploading the PDB file into the VMD program.
The N- terminal and C- terminal domains that were replaced in the cullin chimeras were
selected within the amino acid sequence of Cul1 and displayed as a different color from
the rest of the model.
RESULTS AND DISCUSSION
The chimeric cullin constructs described in this chapter represent a powerful
experimental tool for investigating CRL structure and function. Before experiments were
conducted, all plasmids were sent to Oregon Health Sciences University for sequencing.
Sequence data confirmed that all inserts were correct and in frame.
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The plasmids were then tested for protein expression in cultured cells. FLAG
tagged chimeric and wild type cullin plasmids were transfected into HEK293 cells. Cells
were harvested after 48 hours, lysed, and proteins were separated using SDS PAGE.
Western blotting was then used to visualize proteins. As seen in Figure 2.4, all wild type
and chimeric cullin constructs expressed protein in HEK293 cells. The four chimeric
cullins that were generated are named for the domain of Cul3 that was replaced by that of
Cul1 or Cul2. Thus, the four chimeras generated are denoted Cul1 NTD, Cul2 NTD, Cul1
CTD, and Cul2 CTD. For clarity, a color coded illustration for each cullin and chimera is
provided in Figure 2.4.
Notably, all chimeric cullins appear to be modified with Nedd-8. Because the
neddylated form of cullins has a higher molecular weight, cullins appear as a doublet on a
western blot. As seen in figure 2.3, all wild type and chimeric cullin proteins appear as a
doublet, with the upper and lower bands representing neddylated and unneddylated
forms, respectively. The chimera containing the C- terminus of Cul2 appears to be
neddylated to a lesser extent than the other chimeras, but is comparable to the amount of
neddylation seen in wild type Cul2 (comparing lanes 2 and 7).
The observation that the chimeric cullins are capable of modification with Nedd-8
suggests that chimeras are likely folded into their proper conformation. When
engineering chimeric proteins, it is a concern that the chimeric junction will interrupt the
way in which the protein folds. Since a proper fold is critical for protein function, it is
essential for chimeras to retain their native fold in order for a chimeric study to be of
value. Thus, the observation that the chimeras are capable of modification with Nedd-8
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was exciting, as it provided evidence that the chimeras were properly folded, and would
be useful for conducting experiments.
To illustrate where the chimeric junctions were placed within the molecular
structure of Cul3, we used a modeling program to create a molecular model of a chimeric
cullin protein. Protein data bank coordinates for the crystal structure of Cul1 were used to
create this model. The model is shown in Figure 2.5.
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Figure 2.1: Schematic for chimeric cullin proteins
A) A schematic for the regions corresponding to the N- terminal domains and C- terminal domains of
wild type Cul1, Cul2, and Cul3 proteins. B) N- terminal chimeric cullin proteins in which the NTD of
Cul3 has been replaced by that of Cul1 or Cul2. C) C- terminal chimeric cullin proteins in which the
CTD of Cul3 has been replaced by that of Cul1 or Cul2.

23

Figure 2.2: Chimeric junction placement within the amino acid sequences of Cul1, Cul2, and Cul3
To determine where to place the chimeric junctions within the amino acid sequences of Cul1, Cul2, and
Cul3, an amino acid alignment was performed using ClustalW software. Residues that are conserved
among all three cullins are boxed in black, while residues possessing similar chemistry are boxed in grey.
The N- terminal and C- terminal junctions were chosen in areas of relatively high homology, and are
indicated by red bars.

24

Figure 2.3: Cloning strategy for chimeric cullin constructs
The strategy for the cloning of the N- terminal chimeras is shown. A) The cDNA corresponding to the Nterminal domain (NTD) of Cul1 was amplified by PCR, flanked by the same two restriction sites flanking
the NTD in the Cul3 plasmid. B) Restriction digests were carried out on the wild type Cul3 plasmid and
on the Cul1 NTD PCR product. The digested DNA was combined in a ligation reaction, generating a
plasmid coding for chimeric Cul3 protein: Cul3 with the NTD of Cul1.
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Figure 2.4: Wild type and chimeric cullin expression in HEK 293 cells
HEK 293 cells were transfected with FLAG- tagged wild type or chimeric cullins. Cells were
harvested after 48 hours. Western blotting was performed using FLAG antibody to visualize protein
expression. For clarity, an illustration of each cullin and chimera is provided below each lane. On the
right panel, Cul3 was run on the same gel as the chimeras to illustrate that these proteins are a similar
relative size.
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Figure 2.5: A molecular model for a cullin chimera
A molecular model for a chimeric cullin was generated using VMD molecular dynamics modeling
software. The protein data bank coordinates for the crystal structure of Cul1 in complex with Rbx1 were
used to generate this model. The N- terminal domain encompasses the first two hundred residues of Cul1,
and is shown on the left in red. The residues required for Skp1 interaction within this domain are boxed in
yellow. The C- terminal domain encompasses approximately three hundred residues and is shown on the
right, also in red. The RING protein Rbx1 is shown in green. The chimeric junctions where the protein
domains were swapped can be seen where the color changes from red to purple. While this molecular
model was generated using the coordinates from the crystal structure of the Cul1 protein, it is likely a good
approximation of where the junctions fall within the molecular structure of Cul3.
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CHAPTER III
EXAMINING SUBSTRATE ADAPTER BINDING OF WILD TYPE AND CHIMERIC
CULLINS
ABSTRACT
The chimeric cullin constructs generated in this study represent a valuable
tool for investigating how different functional domains of CRLs contribute to their
specific functions in cells. In order to determine if the chimeras that we engineered were
able to interact with their respective substrate adapters, we performed coimmunoprecipitation experiments in which we tested the ability of wild type, chimeric, or
mutant cullin proteins to bind to three different substrate adapter proteins. We found that
the chimera possessing the C- terminus of Cul1 and the N- terminus of Cul3 retains the
ability to interact with the BTB substrate adapters Ctb57 and KLHL3. We also found that
the chimera that possesses the C- terminus of Cul3 and the N- terminus of Cul1 was
unable to interact with BTB proteins. Lastly, we found that the Cul1 adapter Skp1 was
not able to bind to either chimera.
INTRODUCTION
The chimeric constructs generated in this study have provided us with a useful
tool to investigate how the different functional domains of CRLs contribute to their
unique functions in cells. By swapping out the regions responsible for Rbx1 interaction or
substrate adapter recognition, we can begin to dissect how these regions contribute to
CRL specific function in vivo. Therefore, we first wanted to test if the chimeric cullins
we generated were capable of binding to their respective substrate adapter subunits.
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In this chapter, we examined two of the four cullin chimeras for binding to their
respective substrate adapter subunits. We performed co-immunoprecipitation experiments
to investigate the ability of the chimeras possessing the N- terminus or C- terminus of
Cul1 to bind to BTB proteins, or Skp1 respectively. It should be noted that the chimeras
possessing the N- terminus or C- terminus of Cul2 were not examined due to time
constraints.
In recent years, interactions of substrate adapters with both Cul1 and Cul3 have
been well characterized. Crystallographic analysis of the SCF complex revealed that the
N-terminus and central stalk of Cul1 is comprised of three repeats each made up of five
helices, which is termed the cullin repeat. At the N- terminus of Cul1, the first helical
repeat binds to Skp1, which in turn binds to the F-box protein Skp2 (Zheng et al., 2002).
There are over sixty F-box proteins in mammalian cells, which recognize and bind to
Cul1 substrates through WD40 domains, Leucine rich repeat (LRR domains), or others
(Skaar et al., 2009).
While most CRL complexes interact with substrates via two protein subunits,
Cul3 interacts with substrates through a single polypeptide, which binds Cul3 through a
BTB domain and interacts with substrates through various protein interaction motifs. The
BTB domain was first identified as a conserved sequence found in transcriptional
repressors in Drosophila (Bric-a brac, Tramtrak, and Broad complex) (Zollman et al.,
1994).
Since its discovery, a growing number of proteins possessing a BTB domain have
been identified as putative substrate adapters for Cul3 (Angers et al., 2006; Cullinan et
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al., 2004; Furukawa et al., 2003; Furukawa and Xiong, 2005; Geyer et al., 2003;
Kobayashi et al., 2004; Kwon et al., 2006; Pintard et al., 2003; Salinas et al., 2006; Xu et
al., 2003; Zhang et al., 2005). These BTB proteins bind to the N- terminus of Cul3 via
the BTB domain and recognize protein substrates through protein interaction motifs such
as Kelch, MATH (Mephrin and TRAF Homology), LRR (Leucine rich repeat), or zinc
finger domains. Our laboratory has identified numerous BTB containing proteins that
interact with Cul3 and likely serve as Cul3 substrate adapters (Cummings et al., 2009).
Some of these proteins are novel and some have since been characterized by other
groups. We have designated these proteins Ctb proteins (Cullin three binding).
N- terminal residues of Cul3 that are required for binding to BTB proteins have
begun to be identified based on the related interface between Cul1 and Skp1. Recent
investigations into the structure of the SCF complex suggest that Skp1 interacts with
Cul1 at residues in helix 2 and helix 5 of the N-terminal cullin repeat (Zheng et al., 2002).
Other studies revealed that deletions in analogous helices 2 and 5 at the N terminus of
Cul3 abolishes binding to BTB proteins (Xu et al., 2003),(Pintard et al., 2003). It was
later shown that four amino acids in helix five of Cul3, referred to as the LSFE sequence
(amino acids 52-55), are required for BTB protein binding (Pintard et al., 2004).
In the experiments designed in this chapter, we examined the ability of wild type
and chimeric cullin proteins to bind to two different BTB adapter proteins, Ctb57 and
KLHL3. Ctb57 belongs to the KCTD family, a family of proteins containing a potassium
channel tetramerisation domain (KCTD). Members of this group of proteins play diverse
biological roles and several have recently been shown to serve as Cul3 substrate adapters.
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Ctb57, also called KCTD6, was recently characterized as a Cul3 substrate adapter that
mediates the ubiquitylation of small ankyrin- 1 (sAnk1.5) a protein found in the
sarcoplasmic reticulum of striated muscle cells (Lange et al.).
The other BTB protein used in this study, KLHL3, belongs to the BTB-BACKKelch family of proteins, and has been shown to serve as a Cul3 substrate adapter that
mediates ubiquitylation of WNK4, a serine-threonine kinase shown to regulate sodium
chloride channel function in the kidney (Shibata et al.).
Here we performed binding experiments using two Cul3 chimeras in which the Cterminal and N- terminal regions were replaced by that of Cul1 (denoted as Cul3/Cul1
CTD and Cul3/Cul1 NTD, respectively). We also used a Cul3 mutant lacking the Nterminal amino acids involved in BTB protein binding (Cul3 Δ51-67). This mutant has
been previously shown to be unable to bind Ctb57 or KLHL3. We performed a set of coimmunoprecipitation experiments in which we tested the ability of wild type, mutant, or
Cul3/Cul1 chimeras to bind to either BTB proteins or Skp1 in cultured cells.
We found that the chimera containing the C- terminus of Cul1 and the Nterminus of Cul3 retains the ability to bind to BTB adapter proteins Ctb57 and KLHL3.
Cul1 was unable to bind these BTB proteins, nor was the Cul3 chimera that possessed
the N- terminus of Cul1. These observations suggest that these chimeras have the
functional binding characteristics of a Cul3/Cul1 chimeric protein and may function as
such a chimera in vivo.
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MATERIALS AND METHODS
Cell culture, plasmids and tranfections
HEK 293 cells were grown and transfected as described in Chapter II.
Plasmid DNA: FLAG- tagged wild type and chimeric Cul1 and Cul3 were cloned into
pCMV-3Tag-6 as described in Chapter II. HA-tagged Skp1 was created by cloning Skp1
into the vector CS2+HA. Myc- tagged Ctb57 and KLHL3 were previously cloned by our
laboratory into the vector CS2+MT. FLAG- tagged mutant Cul3 Δ 51-67 was previously
generated by our laboratory, via site- directed mutagenesis on 3XFLAG Cul3.
Immunoprecipitation and Immunoblotting
Cells were harvested and lysed as described in Chapter II. For immunoprecipitation
assays, lysates were incubated with primary antibody for ten minutes, followed by
incubation with sepharose beads containing immobilized protein A (RepliGen
Corporation) for 2 hours at 4°C. The samples were spun down and beads were washed
twice with RIPA. SDS PAGE was used to separate protein in the samples on 10% or 15%
acrylamide gels, followed by a transfer to nitrocellulose membrane. The membranes were
incubated overnight in primary antibodies. Proteins on the membrane were visualized
using

horseradish

peroxidase

conjugated

secondary

antibodies

and

enhanced

chemiluminescence reagent, followed by detection of signal on a digital imager.
Antibodies used for immunoprecipitation: anti- FLAG M2 monoclonal antibody (Sigma
Aldrich). Antibodies used for western blotting: anti- Myc sc-789 polyclonal antibody
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(Santa Cruz Biotechnology, Santa Cruz, California), and anti- FLAG M2 monoclonal
antibody (Sigma Aldrich).
RESULTS AND DISCUSSION
The chimera possessing the N- terminus of Cul3 binds BTB adapter proteins
In order to determine whether the Cul3/Cul1 chimeras were able to bind BTB
domain proteins Ctb57 or KLHL3, we performed co-immunoprecipitation assays using
cultured HEK293 cells. Myc-tagged BTB protein Ctb57 or KHLH3 were cotransfected
separately with FLAG- tagged wild type Cul1, wild type Cul3, chimeric Cul3/Cul1 CTD,
chimeric Cul3/Cul1 NTD, or the BTB binding mutant Cul3 Δ 51-67.

Cells were

harvested after 48 hours and immunoprecipitation was carried out using FLAG antibody,
followed by western blotting for Myc-Ctb57 or Myc-KLHL3 respectively.
As expected, wild type Cul3 binds Ctb57, while wild type Cul1 does not (Figure
3.1, lanes 2 and 3). The chimera that contains the C- terminus of Cul1 and the Nterminus of Cul3 retains its ability to bind Ctb57 (lane 4). Since this chimera contains the
N- terminus of Cul3, this observation is consistent with what we know about where BTB
proteins interact with Cul3. Likewise, the chimera that possesses the N- terminus of Cul1
was not able to bind Ctb57 (lane 5). This is consistent with the observation that wild type
Cul1 does not bind this BTB protein. Lastly, the Cul3 mutant lacking the N- terminal
amino acids 51-67 was not able to bind Ctb57 (lane 6). This observation is consistent
with previous observations that this mutant is unable to bind Ctb57.
We next examined the binding interactions between the Cul3/Cul1 chimeras and
the BTB protein KLHL3. We found that KLHL3 clearly binds to Cul3, but to a much
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lesser degree to Cul1 (Figure 3.2, lanes 2 and 3). The chimeric cullin that contains the Cterminus of Cul1 and the N- terminus of Cul3 also retains its ability to bind KLHL3 (lane
4). Again, this is consistent with the known interaction between BTB proteins and the Nterminus of Cul3. Interestingly, the Cul3/Cul1CTD chimera appears to bind to KLHL3
better than wild type Cul3 (comparing lanes 3 and 4). This observation is interesting
because our laboratory previously noted that KLHL3 exhibits enhanced binding to
Cul3Δ403-459, a Cul3 mutant with a large deletion at the C- terminus. Since Cul3/Cul1
CTD and Cul3Δ403-459 are both lacking a stretch of Cul3 specific sequence at the Cterminus, it is possible that disrupting some unknown structural feature at the C- terminus
of Cul3 somehow leads to enhanced binding of this substrate adapter.
Further, while both Cul3/Cul1 CTD and Cul3Δ403-459 exhibit enhanced binding
to KLHL3, we have also previously observed that both of these mutants display enhanced
ubiquitin laddering of Cul3 substrate cyclin E (data not shown). It is an interesting
possibility that there exists a region in the C- terminus of Cul3, that when disrupted,
enhances assembly with Cul3 substrate adapters as well as ubiquitylation activity. These
observations will lead to interesting future experiments.
In contrast, KLHL3 does interact with the chimera that contains the N- terminus
of Cul1 (lane 5). This is consistent with the observation that this BTB protein binds to
Cul1 to a much smaller degree than Cul3. It is interesting to note that while KLHL3
shows a limited ability to bind to wild type Cul1, it is not able to interact at all with this
chimera which contains the N- terminus of Cul1 (comparing lanes 1 and 5). However,
this observation is likely explained by the lower expression level of this chimera
compared to wild type Cul1 (comparing lanes 2 and 5, lowest panel). Lastly, the Cul3
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mutant lacking the amino acids 51-67 was unable to bind KLHL3 (lane 6). This is in
keeping with previous observations that this mutant does not bind to KLHL3.

The adapter protein Skp1 binds to Cul1, and not to Cul3 or chimeric Cul3 proteins
While Cul3 interacts with substrates through a single polypeptide containing a
BTB domain, other cullin complexes utilize two separate protein subunits that recognize
and recruit substrates. In the SCF complex, Cul1 binds to the adapter protein Skp1, which
in turn binds F-box protein Skp2 that recognizes SCF substrates. Skp1 interacts with the
N terminus of Cul1 at residues in helix 2 and 5 of the N terminal cullin repeat (Zheng et
al., 2002). Analogous residues from helix five of Cul3 have been shown to be required
for Cul3 to bind BTB proteins.
In this experiment, we performed co- immunoprecipitation experiments to
investigate the ability of wild type, chimeric, or mutant cullins to bind to Cul1 adapter
protein Skp1 in cultured HEK293 cells. HA-tagged Skp1 was cotransfected with FLAGtagged Cul1, Cul3, Cul1CTD, Cul1NTD, or Cul3Δ51-67. The cells were harvested after
48 hours and immunoprecipitation was carried out using FLAG antibody. Western
blotting was then used to probe for HA-Skp1.
Skp1 binds to Cul1 (Figure 3.3, lane 2). In contrast, Skp1 was unable to bind any
of the other proteins used in this experiment (lanes 3-6) relative to background (lane 1).
As expected, Skp1 did not bind Cul3 or the chimera that contains the N- terminus of Cul3
(lanes 3 and 4). However, Skp1 was also unable to bind to the Cul3 chimera that contains
the N- terminus of Cul1 (lane 5). Since previous data has shown that Skp1 interacts with
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N- terminal residues of Cul1 that are contained in this chimera, this result was not
anticipated. It is possible that are regions within the C- terminus of Cul1 that are involved
in recruiting Skp1. Alternatively, it is possible that the creation of the chimeric junction
interrupted a structural feature near the N- terminus of Cul1 that is involved in Skp1
binding. Further experimentation will be required to explain the observations for Skp1
interactions.
In conclusion, while the observations for Skp1 interactions are puzzling, useful
information has been gained from the experiments conducted on Cul3 substrate adapters
Ctb57 and KLHL3. The ability of the chimera containing the N- terminus of Cul3 to bind
to these BTB proteins suggests that this chimera possesses the functional binding
capabilities of a Cul1/Cul3 chimera, and may function as such in vivo. Therefore, this
chimera is a good candidate for an in vivo study.
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Figure 3.1: Wild type and chimeric cullin binding to BTB protein Ctb57
HEK 293 cells were cotransfected with Myc- tagged Ctb57 and FLAG- tagged wild type Cul1, Cul3, Nterminal chimeric Cul3, C-terminal chimeric Cul3, or Cul3Δ51-67. Cells were harvested after 48 hours.
Immunoprecipitation was carried out using FLAG antibody and immunoblotting was used to probe for
Myc-Ctb57 binding (top panel). The second panel is a FLAG antibody control, and verifies that the
immunoprecipitation pulled down FLAG- cullins. The lowest two panels indicate expression levels of
Myc- Ctb57 and FLAG- cullin, respectively.
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Figure 3.2: Wild type and chimeric cullin binding to BTB protein KLHL3
HEK 293 cells were cotransfected with Myc- tagged KLHL3 and FLAG- tagged wild type Cul1, Cul3, Nterminal chimeric Cul3, C-terminal chimeric Cul3, or Cul3Δ51-67. Cells were harvested after 48 hours.
Immunoprecipitation was carried out using FLAG antibody and immunoblotting was used to probe for
Myc-KLHL3 binding (top panel). The second panel is a FLAG antibody control, and verifies that
immunoprecipitation pulled down FLAG- cullins. The lowest two panels indicate expression levels of
Myc- KLHL3 and FLAG- cullin, respectively.
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Figure 3.3: Wild type and chimeric cullin binding to adapter protein Skp1
HEK 293 cells were cotransfected with HA- tagged Skp1 and FLAG- tagged wild type Cul1, Cul3, Nterminal chimeric Cul3, C-terminal chimeric Cul3, or Cul3Δ51-67. Cells were harvested after 48 hours.
Immunoprecipitation was carried out using FLAG antibody and immunoblotting was used to probe for HASkp1 binding (top panel). The second panel is a FLAG antibody control, and verifies that the
immunoprecipitation pulled down FLAG- cullins. The lowest two panels indicate expression levels of HASkp1 and FLAG- cullin, respectively.
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CHAPTER IV
ANALYSIS OF E2 INTERACTIONS WITH WILD TYPE AND CHIMERIC CULLINS
ABSTRACT
E2 enzymes have been shown to interact with the highly conserved C- terminus of
cullin RING ligases (CRLs), via the RING protein Rbx1. E2 enzymes work together with
CRLs to attach molecules of ubiquitin to substrates. There are approximately 38 E2
enzymes in humans, and while a growing number of studies have characterized different
E2-E3 pairs, little is known about the specificity of these interactions. Here we performed
co-immunoprecipitation assays to investigate the specific binding interactions between
E2 enzymes and wild type, mutant or chimeric cullin proteins. We found that E2 enzyme
UbE2E1 selectively binds to Cul3 and not to Cull. Notably, the BTB binding region at
the N- terminus of Cul3 is required for binding to UbE2E1. Furthermore, we found that
UbE2E1 also binds to Cul3 substrate adapter protein Ctb57. These experiments revealed
a novel E2 interaction with the N- terminus of Cul3, as well as with a Cul3 substrate
adapter protein.
INTRODUCTION
As discussed in Chapter I, CRLs are structurally similar, yet recognize unique
substrates and thus carry out very different functions in cells. The current model holds
that the C- terminus is highly homologous and binds E2s in a similar way, while the Nterminus is more variable and recruits unique substrates via distinct substrate adapter
modules. However, open questions remain regarding this model. It has been observed
that specific E2s seem to be selected by different CRLs. And, since E2s are thought to be
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responsible for the placement of branching of ubiquitin chains, the choice of E2 is
essential for the type of ubiquitination that occurs. Thus, understanding how CRLs select
different E2s is important for understanding how CRLs carry out unique functions in
cells.
CRLs possess a highly conserved, globular C-terminal domain known as the
cullin domain, that binds ring finger protein Rbx1 (also called RubI, RocI, HrtI), which
serves as a docking site for ubiquitin activated E2 enzymes (Ohta et al., 1999). Based on
the structure of Cul1, the globular C- terminal domain of cullins possesses conserved
residues that bind to Rbx1 through an intermolecular β sheet (Zheng et al., 2002). Rbx1
in turn interacts with E2 enzymes via its RING domain. Nedd-8 modification to a
conserved lysine at the C- terminus of cullins has been shown to activate CRL
complexes, presumably by causing a conformational change which frees the ring domain
of Rbx1, providing a flexibility to the CRL complex that positions the E2 in closer
proximity with substrate for ubiquitin transfer (Duda et al., 2008).
The human genome codes for at least 38 E2 enzymes, many of which are highly
homologous in sequence and structure. E2 enzymes possess a highly conserved 150- 200
amino acid catalytic domain known as the ubiquitin conjugating (UBC) domain, which
contains a catalytic cysteine residue which binds activated ubiquitin (Berleth and Pickart,
1996; Dye and Schulman, 2007; Hershko et al., 1983; Pickart, 2001).

There are four

major classes of E2 enzymes. Class I E2s consist of only a UBC domain, while classes II
and III contain C- terminal and N- terminal extensions flanking the UBC domain. Class
IV E2s possess both C- terminal and N- terminal extensions. These extensions can serve
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different functions, such as interaction with cognate E3s, substrate recruitment, or
dimerization (Kleiger et al., 2009; Summers et al., 2008; Xie et al.).
Recently, a growing number of studies have characterized how E2 enzymes
interact with E3s. The UBC domain is made up of four α helices and an antiparallel β
sheet, and all E2s characterized so far interact with E3s through loop 1, loop 2, and α
helix 1 of the UBC domain. Variations in sequence among different E2s are thought to
contribute to the specificity of interactions with different E3s (Ye and Rape, 2009).
The N- terminal and C- terminal extensions of different E2s can also play diverse
roles in E2/E3 interactions. Class III E2 UbcH10 (UBE2C) is known to act as an E2 for
the E3 anaphase promoting complex (APC), a key player in cell cycle regulation.
UbcH10 possesses an N- terminal extension that regulates ubiquitylation activity and
selects which lysine residues of substrates are modified by the ubiquitin ligase complex
(Summers et al., 2008). Another well- characterized E2 is cell division cycle 34 (Cdc34),
a class II E2 that serves as a cognate E2 for the Cul1/ SCF complex (Goebl et al., 1988;
Skowyra et al., 1997). Cdc34 possesses a C- terminal acidic tail that binds to Cul1.
Phosphorylated residues on the C- terminal tail have been shown to regulate
ubiquitylation activity (Kolman et al., 1992; Silver et al., 1992).
Despite recent advances in E2-E3 interactions, little is known about the specificity
of these interactions. A single E2 can bind to several E3s, but not necessarily in the
same way. Alternately, some E2s seem to interact exclusively with a single E3. Less is
known about the specificity of interactions with E2s and Cullin RING ligases. To date,
relatively few studies have identified E2-CRL cognate pairs. Cdc34 has been well
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characterized as a cognate E2 for the SCF complex, which has been shown to
polyubiquitylate Cdk inhibitor Sic1 (Verma et al., 1997). But to date, Cdc34 has not
been shown to interact with other CRLs.
To identify CRL specific interactions with E2 enzymes, we performed
cotranfections and co- immunoprecipitation assays where we tested the ability of wild
type and chimeric Cul1 and Cul3 to bind to five different E2 enzymes in cultured cells.
We found that one of these E2s bind to both Cul1 and Cul3, while three other E2s did
not bind to either cullin. Interestingly, one E2s displayed selectivity for one cullin over
the other: UbE2E1 bound to Cul3 and not Cul1. Since UbE2E1 showed specificity for
Cul3, we next wanted to explore what part of Cul3 was required for this E2 to bind.
Since the C- termini of cullins are highly homologous, how does a given E2
interact with one cullin and not another? What structural features of cullins are required
to interact with different E2 enzymes? The chimeric cullins provided us with a direct
way to address this question. Therefore, we next performed co- immunoprecipitation
assays where we tested the ability of UbE2E1 to bind to wild type, chimeric, and mutant
cullin proteins.
Surprisingly, we found that the C- terminus of Cul3 was not required for binding
to this E2, but the N- terminus was required. Further, we found that removal of the BTB
binding region of Cul3 significantly diminishes binding to UbE2E1. Additionally, coimunoprecipitation assays performed with UbE2E1 and several different BTB substrate
adapter proteins revealed that UbE2E1 binds to BTB adapter protein Ctb57. Taken
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together, these data reveal a novel interaction between the E2 enzyme UbE2E1 and the
N- terminus of Cul3.
MATERIALS AND METHODS
Cell culture, plasmids and tranfections
HEK 293 cells were grown and transfected as described in Chapter II.
Plasmid DNA: FLAG- tagged wild type Cul1 and Cul3, and chimeric Cul3/Cul1 were
cloned into pCMV-3Tag-6 as described in Chapter II. Cul3 was also cloned into the
vector 3XFLAG. FLAG tagged Cul3 mutants Δ51-67 and Δ403-457 were previously
made by our laboratory using the QuikChange site- directed mutagenesis kit (Agilent
Technologies). Both Cul3 mutations were made on Cul3 that was cloned into the vector
3XFLAG. Myc-tagged E2s (UbE2E1, UbcH5b, UbcH7, and UbcH10) in the vector
pKMyc were donated from the Plafker laboratory (Oklahoma Medical Research
Foundation, Oklahoma City). UbcM2 was cloned into the vector CS2+MT.
Immunoprecipitation and Immunoblotting
Immunoprecipitation and western blotting was performed as described in Chapter III.
Antibodies used for immunoprecipitation: anti- FLAG M2 monoclonal antibody (Sigma
Aldrich), or anti- Myc sc-789 polyclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, California).
Antibodies used for western blotting: anti- Myc sc-789 polyclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, California), and anti- FLAG M2 monoclonal antibody
(Sigma Aldrich)
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RESULTS AND DISCUSSION
Cul1 and Cul3 exhibit differential binding to E2 enzymes
Since little is known about the specificity of interactions between E2s and
different cullins, we first wanted to determine if there were E2 enzymes that showed
selectivity for binding to either Cul1 or Cul3. To investigate this, we cotransfected
FLAG- tagged wild type Cul1 or Cul3 separately with five different Myc- tagged E2s.
Immunoprecipitation was then performed using FLAG antibody, followed by western
blotting to probe for E2 binding.
There were three E2s (UbcH5b, UbcH7, and UbcH10) that did not appear to bind
to either Cul1 or Cul3 (Figure 4.1). To date, none of these E2s have been published to
interact with cullin ligases, but all been characterized for their interactions with other
types of E3 ligases. For example, UbcH5b has been shown to facilitate the ubiquitiylation
of p53 by the E3 ligase Mdm2 (Saville et al., 2004).
One of the E2s tested, UbcM2, was able to bind to both Cul1 and Cul3 (Figure
4.2). UbcM2 has been previously characterized as interacting with Cul1 and Cul3 in an in
vitro study (Plafker et al., 2009), yet its interaction with cullin complexes in vivo had not
yet been tested.
Interestingly, one of the E2s tested appeared to be selective for Cul3. UbE2E1
was shown to bind to Cul3, but not to Cul1 (Figure 4.3). This E2 was previously
characterized for its role in histone ubiquitination (Plafker et al.; Sarkari et al.), but had
not been characterized for interaction with any of the cullin ligases.
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The selectivity observed in this experiment raises several interesting questions.
Since the C- terminus of Cul1 and Cul3 are highly homologous, and both interact with
Rbx1 in a similar way, how does a single E2 interact with one cullin and not the other?
What features of these two cullins are responsible for differential binding to a single E2?
To begin to address these questions, we next performed a set of binding experiments with
UbE2E1 and Cul3/Cul1 chimeric cullins.
The BTB region of Cul3 is required for binding to E2 enzyme UbE2E1
Since we had observed that UbE2E1 binds to Cul3 and was unable to interact with
Cul1, we wanted to determine which part of Cul3 was required for UbE2E1 binding. To
investigate this, we performed cotransfections and co-immunoprecipitation experiments
to examine binding interactions between this E2 and chimeric Cul3/Cul1 proteins or
mutant cullin proteins.
HEK293 cells were cotransfected with Myc-tagged UbE2E1 and FLAG-tagged
wild type Cul1, wild type Cul3, chimeric Cul3 possessing the C- terminus of Cul1
(Cul1CTD), Cul3 possessing the N- terminus of Cul1 (Cul1NTD), a mutant Cul3 lacking
the N- terminal residues involved in BTB domain binding (Cul3Δ51-67), or a mutant
Cul3 lacking a large region of the C terminus (Cul3Δ403-459). Immunoprecipitation with
FLAG antibody was then performed, followed by western blotting to probe for MycUbE2E1 binding.
The current model of CRL assembly suggests that E2 enzymes interact with cullin
based E3s via interaction with the ring domain protein Rbx1 at the C- terminus of cullins.
Since UbE2E1 was able to bind to Cul3 and not to Cul1, we expected that the Cul3
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chimera that contained the C- terminus of Cul1 would not be able to bind this E2. We
were surprised to see that this did not occur (Figure 4.4, lane 4). In fact, the C- terminal
chimera appeared to have an enhanced ability to bind this E2. Also, the mutant Cul3 that
contains a large deletion at the C terminus (Cul3Δ403-459) was also able to interact with
UbE2E1 (lane 7). These observations suggest that the C- terminus of Cul3 is not required
for binding to this E2.
Further, we expected that replacing the N- terminus of Cul3 with that of Cul1
would have little effect on the binding of this E2, as the current model suggests that the
N- terminus is not involved. Surprisingly, replacing the N- terminus of Cul3 with that of
Cul1 eliminated binding (lane 5). Moreover, the Cul3 mutant lacking the residues
involved in BTB protein binding (Cul3Δ51-67) also significantly diminished binding
(lane 6). Taken together, these data suggest that the N- terminus, specifically the BTB
binding region, is required for UbE2E1 interaction with Cul3.
These observations do not align with the current model of how cullin E3 ligases
interact with E2s. However, as more E2- E3 interactions are characterized, it becomes
clear that E2s can in fact interact with E3s in variable ways. However, to date, the only
example of an E2 interaction with the N- terminus of CRL complexes was seen between
the metazoan E2 UbcM2 and Cul3.
As previously mentioned, an in vitro transcription/ translation study revealed that
UbcM2 interacts with the N- terminus of Cul3, and requires the BTB binding region as
well as the presence of a substrate adapter to bind to the cullin complex (Plafker et al.,
2009). The same study also showed that UbE2E1 and UbE2E2 bind the N terminus of
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Cul3 in vitro, suggesting that interaction with the N- terminus of cullin complexes may
be a trait shared by all class III E2s.
It is an interesting possibility that BTB substrate adapters, or the N- terminus of
Cul3 itself is somehow involved in recruiting certain E2s to the Cul3 complex.
Alternatively, another possibility is that UbE2E1 is not serving as an ubiquitin
conjugating enzyme with Cul3 but is instead bound to Cul3 as a substrate. Since
substrates are recruited to the Cul3 complex by BTB proteins at the N terminus, this
could explain the observation that the BTB binding domain of Cul3 is required for this
UbE2E1 to bind. To investigate these observations further, we next tested the ability of
this E2 to interact with BTB domain containing proteins.
UbE2E1 binds to the Cul3 adapter protein Ctb57
Since we had shown that the N- terminus of Cul3 is required for interaction with
UbE2E1, we wanted to determine whether it is interacting directly with the N- terminus
of Cul3, or to a substrate adapter protein of the Cul3 complex. To begin to investigate
this, HEK293 cells were cotransfected with HA-tagged UbE2E1 and five different Myctagged BTB proteins previously shown to interact with Cul3 (Ctb3, Ctb57, Ctb73, Ctb75,
and KLHL3). Immunoprecipitation was then performed with HA antibody followed by
western blotting to probe for BTB protein interaction. It should be noted that one of the
BTB proteins in this experiment did not express (Ctb3, lane 2 middle panel), and so no
conclusion can be drawn about the interaction between Ctb3 and UbE2E1 from this
experiment. However, of the five BTB domain proteins tested, one protein (Ctb57)
displayed a strong interaction with UbE2E1 (Figure 4.5, lane 3).
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As discussed in Chapter III, Ctb57 is a member of the KCTD (potassium channel
tetramerization domain) family of BTB proteins, and has been characterized as a Cul3
substrate adapter that targets small ankyrin- 1, a protein found in striated muscle cells
(Lange et al.). To date, this BTB protein has not been observed to interact with E2
enzymes. Thus, this experiment revealed a novel interaction between UbE2E1 and Ctb57.
Taken together, the observations that UbE2E1 requires the BTB binding region to
bind Cul3 and also interacts with the Cul3 substrate adapter Ctb57 can be explained in
more than one way. One possibility is that UbE2E1 is recruited to the Cul3 complex by
certain BTB substrate adapters such as Ctb57. Though to date such an interaction has not
yet been observed, it is possible that certain BTB proteins bind both an E2 and substrates,
bringing them in close proximity to each other for ubiquitin transfer.
One way to further investigate this idea would be to determine which part of
Ctb57 binds UbE2E1. As discussed previously, the BTB domain of Ctb57 interacts with
the N- terminus of Cul3 while a separate domain acts to recognize substrates. Therefore,
to determine which part of Ctb57 binds UbE2E1, the next step would be to perform
binding assays on mutant versions of Ctb57 in which the BTB domain or substrate
interaction domains have been disrupted. Unfortunately, at the time of this writing our
laboratory does not yet possess mutants for Ctb57. Therefore those experiments will be
delayed until Ctb57 mutagenesis can be performed and confirmed.
The possibility remains that UbE2E1 is not serving as an ubiquitin conjugating
enzyme with the Cul3 complex, but is instead bound by Cul3/Ctb57 as a substrate. To
investigate this further, two approaches could be taken. First, since all E2s described so
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far have been shown to interact with Ring E3 ligases via RING domain proteins, we
could test the ability of this E2 to bind to a Cul3 mutant that is unable to bind Rbx1.
Thus, it could be determined if UbE2E1 requires Rbx1 to bind Cul3. Another approach
would be to perform ubiquitination assays, to determine if UbE2E1 is ubiquitinated in the
presence of Cul3. This information would further clarify the interaction between Cul3
and UbE2E1.
The experiments described in this chapter provided interesting new information
regarding CRL interactions with E2 enzymes. The work described here identified two E2
enzymes (UbCM2 and UbE2E1) that interact with CRLs and had not been previously
characterized in vivo. Further, this work identified a novel interaction between Cul3 and
UbE2E1. While more experimentation is required to further clarify this interaction, it
represents interesting preliminary data for further investigation.
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Figure 4.1: E2 enzymes UbcH5b, UbcH7, and UbcH10 do not bind either Cul1 or Cul3
HEK 293 cells were cotransfected with Myc- tagged E2 enzymes and FLAG- tagged Cul1 or Cul3. Cells
were harvested after 48 hours. Immunoprecipitation was carried out using FLAG antibody and
immunoblotting was used to probe for Myc-E2 binding. (A, B, C) Myc- signal was not detected,
indicating that these E2s do not bind Cul1 or Cul3 (top panels). The second panel is a FLAG antibody
control, and verifies that the immunoprecipitation pulled down FLAG- cullins. The lowest two panels
indicate expression levels of Myc- E2 and FLAG- cullin, respectively.
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Figure 4.2: E2 enzyme UbcM2 binds both Cul1 and Cul3
HEK 293 cells were cotransfected with Myc- tagged UbcM2 and FLAG- tagged Cul1 or Cul3. Cells were
harvested after 48 hours. Immunoprecipitation was carried out using FLAG antibody and immunoblotting
was used to probe for Myc-UbcM2 binding (top panel). The lowest two panels indicate expression levels
of Myc- UbcM2 and FLAG- cullin, respectively.

Figure 4.3: E2 enzyme UbE2E1 binds Cul3 and not Cul1
HEK 293 cells were cotransfected with Myc- tagged UbE2E1 and FLAG- tagged Cul1 or Cul3. Cells were
harvested after 48 hours. Immunoprecipitation was carried out using FLAG antibody and immunoblotting
was used to probe for Myc- UbE2E1 binding (top panel). The second panel is a FLAG antibody control,
and verifies that the immunoprecipitation pulled down FLAG- cullins. The lowest two panels indicate
expression levels of Myc- UbE2E1 and FLAG- cullin, respectively.
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Figure 4.4: Wild type and chimeric cullin binding to E2 enzyme Ube2E1
HEK 293 cells were cotransfected with Myc- tagged Ube2E11 and FLAG- tagged wild type Cul1, Cul3, N
terminal chimeric Cul3, C-terminal chimeric Cul3, Cul3Δ51-67, or Cul3Δ403-459. Cells were harvested
after 48 hours. Immunoprecipitation was carried out using FLAG antibody and immunoblotting was used to
probe for Myc-Ube2E1 binding (top panel). The second panel is a FLAG antibody control, and verifies that
the immunoprecipitation pulled down FLAG- cullins. The lowest two panels indicate expression levels of
Myc- UbE2E1 and FLAG- cullin, respectively. For clarity, an illustration of wild type and chimeric cullins
is provided below lanes 2-5.
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Figure 4.5: E2 enzyme Ube2E1 binding to BTB proteins
HEK 293 cells were cotransfected with HA- tagged Ube2E1 and 5 different Myc- tagged BTB domain
proteins (Ctb3, Ctb57, Ctb73, Ctb75, and KLHL3. Cells were harvested after 48 hours.
Immunoprecipitation was carried out using Myc antibody and immunoblotting was used to probe for HAUbe2E1 binding (top panel). The lowest two panels indicate expression levels of Myc- BTB proteins and
HA-UbE2E1 respectively.
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CHAPTER V
SIGNIFICANCE AND FUTURE DIRECTIONS FOR THIS STUDY
The chimeric cullins generated in this study have contributed valuable
information to the current body of knowledge regarding CRL complexes in cells. In
Chapter IV, the chimeric cullins allowed us to identify an E2 enzyme, UbE2E1, which
appears to engage in a novel interaction with the N- terminus of Cul3 and with the BTB
protein Ctb57. Thus, by replacing replace large regions of the Cul3 protein with regions
from closely related homologues, we have begun to map which regions of Cul3 are
involved in Cul3 interactions with other proteins.
The results described in this thesis have also generated interesting new questions
to address in future experiments. For example, in Chapter III we observed that the
chimera possessing the C- terminus of Cul1 displayed an enhanced ability to bind the
Cul3 substrate adapter KLHL3. As discussed previously, this observation was intriguing
because we have also observed enhanced binding of KLHL3 by the mutant Cul3 Δ 403459. Moreover, both the Cul1CTD chimera and Cul3 Δ 403-459 have displayed an
enhanced ability to ubiquitinate cyclin E.
Since both of these mutants lack a stretch of Cul3 residues near the C- terminus, it
is an intriguing possibility that disrupting this region somehow activates the Cul3
complex. In fact, a similar observation was seen recently by another group, in a study
conducted on the SCF complex. In that study, deletion of extreme C- terminal residues of
Cul1 dramatically increased the ability of the SCF complex to bind and ubiquitinate a
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Cul1 substrate. The authors suggested that the interface with Rbx1 and the extreme Cterminal residues of Cul1 play an autoinhibitory role, and that when disrupted, activates
the Cul1 complex (Yamoah et al., 2008). It is possible that a similar regulatory
mechanism exists within the Cul3 residues 403-459 near the C- terminus of Cul3. These
ideas will require further investigation, but could uncover an undescribed regulatory
mechanism for Cul3 activity.
The experiments in Chapter IV also generated interesting questions for further
investigation. In these experiments, we observed that the E2 enzyme UbE2E1 displays a
novel interaction with the N- terminus of Cul3 and the BTB adapter protein Ctb57. This
was an interesting observation, as no E2s characterized so far have been shown to interact
with the N- terminus of cullins in vivo. It is possible that this interaction represents a new
role for Cul3 substrate adapters in recruiting E2s for ubiquitin transfer. Alternately, it is
possible that this E2 is not acting as an ubiquitin conjugating E2, but is instead bound to
Cul3 as a substrate. These possibilities are illustrated in Figure 5.1.
To further investigate the interaction between UbE2E1 and Cul3, several
approaches could be taken. First, we could investigate if this E2 also requires Rbx1 to
bind the Cul3 complex. Our laboratory possesses a Cul3 point mutant (Cul3 F665D) that
is unable to bind Rbx1. Therefore, a co- immunoprecipitation experiment will be carried
out to see if UbE2E1 binds this Cul3 mutant. If UbE2E1 does not bind Cul3 F665D, then
that would suggest that UbE2E1 requires Rbx1 to bind Cul3. That would be an
interesting result, because it would suggest that this E2 is binding both Rbx1 at the C-
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terminus of Cul3, as well as interacting with a substrate adapter at the N- terminus of
Cul3.
If UbE2E1 does bind Cul3F665D, this would also be an interesting result, because
it would suggest a previously undescribed interaction of an E2 with only the N- terminus
of a CRL complex. This observation would provide additional evidence for the
possibility that UbE2E1 is a substrate of the Cul3 complex. While E2s have been shown
to be regulated by auto-ubiquitination, little is known about the ubiquitination of E2s by
other E2/E3 pairs. Therefore, to investigate if UbE2E1 is a substrate of Cul3, we could
test to see if UbE2E1 is ubiquitinated by Cul3 in vivo. These experiments will further
clarify the interaction observed between these important proteins.
The ultimate aim for the work described in this thesis is to map the functional
regions of Cul3 that are responsible for its unique activity in cells. Therefore, an
important goal for this project is to perform complementation assays to determine if
chimeric cullin proteins are capable of performing Cul3 functions in vivo. This
information will contribute to our understanding of what parts of the Cul3 contribute to
Cul3 specific functions.
As mentioned in Chapter I, our laboratory possesses a conditional knock out of
Cul3. We possess mouse embryonic fibroblasts (MEFs) that contain two copies of the
Cul3 allele flanked by LoxP sites, as well as an inducible Cre recombinase transgene.
The addition of the drug tamoxifen to these cell lines induces recombination by Cre,
resulting in the removal of the Cul3 allele. This system allows us to tightly control the
expression of endogenous Cul3. Therefore, complementation assays can be performed in
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which we can test the ability of the chimeric cullins to rescue, or complement, the
phenotypes associated with the loss of Cul3.
Because Cul3 is essential for a wide range of processes, the loss of Cul3 will have
observable phenotypes in these cell lines. Just as the loss of Cul3 in mice results in early
embryonic arrest, deletion of Cul3 in MEF cell lines drastically reduces cell viability.
Therefore, one complementation assay that will be performed with the cullin chimeras
will be to determine if expression of a chimera can restore viability to cells in which
endogenous Cul3 has been deleted. If a given chimera can restore viability, then that
would suggest that the chimera is capable of performing Cul3 essential functions.
Since the loss of Cul3 will likely have other observable phenotypes beyond cell
viability, other complementation assays can also be performed with the cullin chimeras.
For example, we could look at the ability of a chimera to ubiquitinate Cul3 specific
substrates. Alternately, we could use flow cytometry to establish cell cycle profiles for
cell lines with and without Cul3, and then examine if a chimera is able to complement the
cell cycle profile associated with the loss of Cul3. These experiments will provide
valuable information regarding the regions of Cul3 that are required for its many
important activities in cells. In this way, the chimeras generated in this study will
continue to be a valued tool for investigations in our laboratory.
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Figure 5.1: Models for UbE2E1 interaction with the Cul3 complex
A) The current model for the assembly of the Cul3 complex. The C- terminus of Cul3 binds the RING
protein Rbx1, which serves as a docking site for ubiquitin activated E2 enzymes. An E2 enzyme transfers
ubiquitin to Cul3 substrates, which are bound by BTB substrate adapter proteins at the N- terminus of Cul3.
In this study, we observed that the N- terminus of Cul3 is required for binding E2 enzyme UbE2E1. This
observation could be explained by two alternate models shown here. B) One possibility is that BTB
substrate adapters are participating in E2 recruitment, and that certain E2s interact with both BTB substrate
adapters and Rbx1 to transfer ubiquitin to substrates. C) An alternate possibility is that the E2 UbE2E1 is
bound to the Cul3 complex as a substrate, and is ubiquitinated by Cul3 and a different E2. Future
experiments will be performed to further investigate these interactions.
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